Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-19-028337
Filing Date
2019-05-08
Accepted
2019-05-08 18:47:40
Documents
3
Period of Report
2019-05-08

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 10916
2 POA DOCUMENT poa.txt EX-24.3_851428 3869
3 EX-24.2 DOCUMENT attachment1.htm EX-24.2 3930
  Complete submission text file 0001209191-19-028337.txt   20265
Mailing Address
Business Address
LAMOND PIERRE (Reporting) CIK: 0001190683 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38890 | Film No.: 19808232

Mailing Address 269 EAST GRAND AVE SOUTH SAN FRANCISCO CA 94080
Business Address 269 EAST GRAND AVE SOUTH SAN FRANCISCO CA 94080 415-910-5717
Cortexyme, Inc. (Issuer) CIK: 0001662774 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 167 ISABELLA AVENUE ALBERTON CA 94027
Business Address
Lamond Christine (Reporting) CIK: 0001775830 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38890 | Film No.: 19808231